Effect of macrolides on peripheral arterial disease depends on patient selection and adequate treatment.
Krayenbuehl
P-A
PA
Wiesli
P
P
Meier
T
T
Schulthess
G
G
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D017963:Azithromycin / Q000627:therapeutic use; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use*; D018579:Patient Selection; D016491:Peripheral Vascular Diseases / Q000188:drug therapy; D015575:Roxithromycin / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D018942:Macrolides; D015575:Roxithromycin; D017963:Azithromycin